South Korea · Delayed Price · Currency is KRW Daewon Pharmaceutical Statistics
Total Valuation
KRX:003220 has a market cap or net worth of KRW 283.78 billion. The enterprise value is 430.25 billion.
| Market Cap | 283.78B |
| Enterprise Value | 430.25B |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
KRX:003220 has 21.43 million shares outstanding. The number of shares has decreased by -0.09% in one year.
| Current Share Class | 21.43M |
| Shares Outstanding | 21.43M |
| Shares Change (YoY) | -0.09% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 38.80% |
| Owned by Institutions (%) | 11.99% |
| Float | 12.84M |
Valuation Ratios
The trailing PE ratio is 30.97 and the forward PE ratio is 23.25. KRX:003220's PEG ratio is 0.33.
| PE Ratio | 30.97 |
| Forward PE | 23.25 |
| PS Ratio | 0.47 |
| PB Ratio | 1.01 |
| P/TBV Ratio | 1.31 |
| P/FCF Ratio | 7.26 |
| P/OCF Ratio | 3.54 |
| PEG Ratio | 0.33 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.92, with an EV/FCF ratio of 11.01.
| EV / Earnings | 52.70 |
| EV / Sales | 0.71 |
| EV / EBITDA | 9.92 |
| EV / EBIT | 19.77 |
| EV / FCF | 11.01 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.65.
| Current Ratio | 1.12 |
| Quick Ratio | 0.55 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 4.24 |
| Debt / FCF | 4.63 |
| Interest Coverage | 2.53 |
Financial Efficiency
Return on equity (ROE) is 1.68% and return on invested capital (ROIC) is 2.83%.
| Return on Equity (ROE) | 1.68% |
| Return on Assets (ROA) | 2.27% |
| Return on Invested Capital (ROIC) | 2.83% |
| Return on Capital Employed (ROCE) | 5.63% |
| Revenue Per Employee | 470.57M |
| Profits Per Employee | 6.36M |
| Employee Count | 1,283 |
| Asset Turnover | 1.04 |
| Inventory Turnover | 2.79 |
Taxes
In the past 12 months, KRX:003220 has paid 5.37 billion in taxes.
| Income Tax | 5.37B |
| Effective Tax Rate | 53.27% |
Stock Price Statistics
The stock price has decreased by -10.41% in the last 52 weeks. The beta is 0.26, so KRX:003220's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -10.41% |
| 50-Day Moving Average | 13,159.40 |
| 200-Day Moving Average | 13,773.55 |
| Relative Strength Index (RSI) | 58.90 |
| Average Volume (20 Days) | 16,816 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:003220 had revenue of KRW 603.74 billion and earned 8.16 billion in profits. Earnings per share was 381.36.
| Revenue | 603.74B |
| Gross Profit | 279.93B |
| Operating Income | 21.13B |
| Pretax Income | 10.08B |
| Net Income | 8.16B |
| EBITDA | 42.73B |
| EBIT | 21.13B |
| Earnings Per Share (EPS) | 381.36 |
Balance Sheet
The company has 42.82 billion in cash and 181.04 billion in debt, giving a net cash position of -138.22 billion or -6,448.74 per share.
| Cash & Cash Equivalents | 42.82B |
| Total Debt | 181.04B |
| Net Cash | -138.22B |
| Net Cash Per Share | -6,448.74 |
| Equity (Book Value) | 279.95B |
| Book Value Per Share | 12,676.42 |
| Working Capital | 24.86B |
Cash Flow
In the last 12 months, operating cash flow was 80.09 billion and capital expenditures -41.01 billion, giving a free cash flow of 39.08 billion.
| Operating Cash Flow | 80.09B |
| Capital Expenditures | -41.01B |
| Free Cash Flow | 39.08B |
| FCF Per Share | 1,823.40 |
Margins
Gross margin is 46.37%, with operating and profit margins of 3.50% and 1.35%.
| Gross Margin | 46.37% |
| Operating Margin | 3.50% |
| Pretax Margin | 1.67% |
| Profit Margin | 1.35% |
| EBITDA Margin | 7.08% |
| EBIT Margin | 3.50% |
| FCF Margin | 6.47% |
Dividends & Yields
This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 2.30%.
| Dividend Per Share | 300.00 |
| Dividend Yield | 2.30% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 78.76% |
| Buyback Yield | 0.09% |
| Shareholder Yield | 2.37% |
| Earnings Yield | 2.88% |
| FCF Yield | 13.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 7, 2022. It was a forward split with a ratio of 1.03.
| Last Split Date | Mar 7, 2022 |
| Split Type | Forward |
| Split Ratio | 1.03 |
Scores
KRX:003220 has an Altman Z-Score of 2.45 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.45 |
| Piotroski F-Score | 4 |